1368488
2011
1
heidelberg-university-faculty-of-medicine
50
creator
asc
year
1
795
https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22FKIAEBCV%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ali%20et%20al.%22%2C%22parsedDate%22%3A%222011%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAli%2C%20M.%20A.%2C%20Bastian%2C%20S.%2C%20Ismail%2C%20R.%2C%20Choon%2C%20T.%20S.%2C%20Ali%2C%20S.%2C%20Aubry%2C%20A.%2C%20Pandian%2C%20S.%2C%20Saraswat%2C%20P.%2C%20Singh%2C%20A.%20and%20Gaur%2C%20R.%20%282011%29.%20%3Cb%3EDiscovery%20of%20novel%20methanone%20derivatives%20acting%20as%20antimycobacterial%20agents%3C%5C%2Fb%3E.%20Journal%20of%20Enzyme%20Inhibition%20and%20Medicinal%20Chemistry%20%3Ci%3E26%3C%5C%2Fi%3E%2C%20890%26%23x2013%3B894%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3109%5C%2F14756366.2011.559945%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3109%5C%2F14756366.2011.559945%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Discovery%20of%20novel%20methanone%20derivatives%20acting%20as%20antimycobacterial%20agents%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohamed%20Ashraf%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvaine%22%2C%22lastName%22%3A%22Bastian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rusli%22%2C%22lastName%22%3A%22Ismail%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tan%20Soo%22%2C%22lastName%22%3A%22Choon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sadath%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suresh%22%2C%22lastName%22%3A%22Pandian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pankaj%22%2C%22lastName%22%3A%22Saraswat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhimanyu%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramakant%22%2C%22lastName%22%3A%22Gaur%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2212%5C%2F2011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.3109%5C%2F14756366.2011.559945%22%2C%22ISSN%22%3A%221475-6366%2C%201475-6374%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Finformahealthcare.com%5C%2Fdoi%5C%2Fabs%5C%2F10.3109%5C%2F14756366.2011.559945%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T09%3A49%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22F8H39A3E%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Antoun%20and%20Veziris%22%2C%22parsedDate%22%3A%222011-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAntoun%2C%20F.%20and%20Veziris%2C%20N.%20%282011%29.%20%3Cb%3EGestion%20des%20tuberculoses%20multir%26%23xE9%3Bsistantes%3C%5C%2Fb%3E.%20Revue%20des%20Maladies%20Respiratoires%20%3Ci%3E28%3C%5C%2Fi%3E%2C%20956%26%23x2013%3B957%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2011.06.010%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2011.06.010%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Gestion%20des%20tuberculoses%20multir%5Cu00e9sistantes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Antoun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22October%202011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.rmr.2011.06.010%22%2C%22ISSN%22%3A%220761-8425%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS076184251100338X%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A58%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22SZDG7VRE%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bastian%20et%20al.%22%2C%22parsedDate%22%3A%222011-02-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBastian%2C%20S.%2C%20Veziris%2C%20N.%2C%20Roux%2C%20A.-L.%2C%20Brossier%2C%20F.%2C%20Gaillard%2C%20J.-L.%2C%20Jarlier%2C%20V.%20and%20Cambau%2C%20E.%20%282011%29.%20%3Cb%3EAssessment%20of%20Clarithromycin%20Susceptibility%20in%20Strains%20Belonging%20to%20the%20Mycobacterium%20abscessus%20Group%20by%20erm%2841%29%20and%20rrl%20Sequencing%3C%5C%2Fb%3E.%20Antimicrob%20Agents%20Chemother%20%3Ci%3E55%3C%5C%2Fi%3E%2C%20775%26%23x2013%3B781%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.00861-10%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.00861-10%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Assessment%20of%20Clarithromycin%20Susceptibility%20in%20Strains%20Belonging%20to%20the%20Mycobacterium%20abscessus%20Group%20by%20erm%2841%29%20and%20rrl%20Sequencing%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvaine%22%2C%22lastName%22%3A%22Bastian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Laure%22%2C%22lastName%22%3A%22Roux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Louis%22%2C%22lastName%22%3A%22Gaillard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22Clarithromycin%20was%20the%20drug%20of%20choice%20for%20Mycobacterium%20abscessus%20infections%20until%20inducible%20resistance%20due%20to%20erm%2841%29%20was%20described.%20Because%20M.%20abscessus%20was%20split%20into%20M.%20abscessus%20sensu%20stricto%2C%20Mycobacterium%20massiliense%2C%20and%20Mycobacterium%20bolletii%2C%20we%20looked%20for%20erm%2841%29%20in%20the%20three%20species%20and%20determined%20their%20clarithromycin%20susceptibility%20levels.%20Ninety%20strains%20were%20included%3A%2087%20clinical%20strains%20from%20cystic%20fibrosis%20patients%20%2861%25%29%20and%20others%20%2839%25%29%2C%20representing%2043%20M.%20abscessus%2C%2030%20M.%20massiliense%2C%20and%2014%20M.%20bolletii%20strains%20identified%20on%20a%20molecular%20basis%2C%20and%203%20reference%20strains.%20Clarithromycin%20and%20azithromycin%20MICs%20were%20determined%20by%20broth%20microdilution%20and%20Etest%20with%20a%2014-day%20incubation%20period.%20Mutations%20in%20rrl%20%2823S%20rRNA%20gene%29%20known%20to%20confer%20acquired%20clarithromycin%20resistance%20were%20also%20sought.%20erm%2841%29%20was%20detected%20in%20all%20strains%20but%20with%20two%20deletions%20in%20all%20M.%20massiliense%20strains.%20These%20strains%20were%20indeed%20susceptible%20to%20clarithromycin%20%28MIC90%20of%201%20%5Cu03bcg%5C%2Fml%29%20except%20for%20four%20strains%20with%20rrl%20mutations.%20M.%20abscessus%20strains%20harbored%20an%20intact%20erm%2841%29%20but%20had%20a%20T%5C%2FC%20polymorphism%20at%20the%2028th%20nucleotide%3A%20T28%20strains%20%28Trp10%20codon%29%20demonstrated%20inducible%20clarithromycin%20resistance%20%28MIC90%20of%20%3E16%20%5Cu03bcg%5C%2Fml%29%2C%20while%20C28%20strains%20%28Arg10%29%20were%20susceptible%20%28MIC90%20of%202%20%5Cu03bcg%5C%2Fml%29%20except%20for%20two%20strains%20with%20rrl%20mutations.%20M.%20bolletii%20strains%20had%20erm%2841%29%20sequences%20similar%20to%20the%20sequence%20of%20the%20T28%20M.%20abscessus%20group%2C%20associated%20with%20inducible%20clarithromycin%20resistance%20%28MIC90%20of%20%3E16%20%5Cu03bcg%5C%2Fml%29.%20erm%2841%29%20sequences%20appeared%20species%20specific%20within%20the%20M.%20abscessus%20group%20and%20were%20fully%20concordant%20with%20clarithromycin%20susceptibility%20when%20erm%2841%29%20sequencing%20was%20associated%20with%20detection%20of%20rrl%20mutations.%20Clarithromycin-resistant%20strains%2C%20including%20the%20six%20rrl%20mutants%2C%20were%20more%20often%20isolated%20in%20cystic%20fibrosis%20patients%2C%20but%20this%20was%20not%20significantly%20associated%20with%20a%20previous%20treatment.%22%2C%22date%22%3A%2202%5C%2F01%5C%2F2011%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.00861-10%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Faac.asm.org%5C%2Fcontent%5C%2F55%5C%2F2%5C%2F775%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-25T16%3A09%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22KZ586QB6%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bouakaze%20et%20al.%22%2C%22parsedDate%22%3A%222011-09-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBouakaze%2C%20C.%2C%20Keyser%2C%20C.%2C%20Gonzalez%2C%20A.%2C%20Sougakoff%2C%20W.%2C%20Veziris%2C%20N.%2C%20Dabernat%2C%20H.%2C%20Jaulhac%2C%20B.%20and%20Ludes%2C%20B.%20%282011%29.%20%3Cb%3EMatrix-Assisted%20Laser%20Desorption%20Ionization-Time%20of%20Flight%20Mass%20Spectrometry-Based%20Single%20Nucleotide%20Polymorphism%20Genotyping%20Assay%20Using%20iPLEX%20Gold%20Technology%20for%20Identification%20of%20Mycobacterium%20tuberculosis%20Complex%20Species%20and%20Lineages%3C%5C%2Fb%3E.%20J%20Clin%20Microbiol%20%3Ci%3E49%3C%5C%2Fi%3E%2C%203292%26%23x2013%3B3299%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.00744-11%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.00744-11%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Matrix-Assisted%20Laser%20Desorption%20Ionization-Time%20of%20Flight%20Mass%20Spectrometry-Based%20Single%20Nucleotide%20Polymorphism%20Genotyping%20Assay%20Using%20iPLEX%20Gold%20Technology%20for%20Identification%20of%20Mycobacterium%20tuberculosis%20Complex%20Species%20and%20Lineages%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Bouakaze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Keyser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Gonzalez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Dabernat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Jaulhac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Ludes%22%7D%5D%2C%22abstractNote%22%3A%22The%20major%20goal%20of%20the%20present%20study%20was%20to%20investigate%20the%20potential%20use%20of%20a%20novel%20single%20nucleotide%20polymorphism%20%28SNP%29%20genotyping%20technology%2C%20called%20iPLEX%20Gold%20%28Sequenom%29%2C%20for%20the%20simultaneous%20analysis%20of%2016%20SNPs%20that%20have%20been%20previously%20validated%20as%20useful%20for%20identification%20of%20Mycobacterium%20tuberculosis%20complex%20%28MTBC%29%20species%20and%20classification%20of%20MTBC%20isolates%20into%20distinct%20genetic%20lineages%2C%20known%20as%20principal%20genetic%20groups%20%28PGGs%29%20and%20SNP%20cluster%20groups%20%28SCGs%29.%20In%20this%20context%2C%20we%20developed%20a%2016-plex%20iPLEX%20assay%20based%20on%20an%20allele-specific-primer%20single-base-extension%20reaction%20using%20the%20iPLEX%20Gold%20kit%20%28Sequenom%29%2C%20followed%20by%20matrix-assisted%20laser%20desorption%20ionization-time%20of%20flight%20mass%20spectrometry%20%28MALDI-TOF%20MS%29%20analysis%20on%20the%20commercially%20available%20Sequenom%20MassARRAY%20platform.%20This%20assay%20was%20tested%20on%20a%20panel%20of%2055%20well-characterized%20MTBC%20strains%20that%20were%20also%20genotyped%20for%20the%20same%20loci%20using%20the%20previously%20reported%20SNaPshot%20assay%2C%20as%20well%20as%2010%20non-MTBC%20mycobacteria%20and%204%20bacteria%20not%20belonging%20to%20the%20genus%20Mycobacterium.%20All%20MTBC%20samples%20were%20successfully%20analyzed%20with%20the%20iPLEX%20assay%2C%20which%20yielded%20clear%20allelic%20data%20for%2099.9%25%20of%20the%20SNPs%20%28879%20out%20of%20880%29.%20No%20false-positive%20results%20were%20obtained%20with%20the%20negative%20controls.%20Compared%20to%20the%20SNaPshot%20assay%2C%20the%20newly%20developed%2016-plex%20iPLEX%20assay%20produced%20fully%20concordant%20results%20that%20allowed%20reliable%20differentiation%20of%20MTBC%20species%20and%20recognition%20of%20lineages%2C%20thus%20demonstrating%20its%20potential%20value%20in%20diagnostic%2C%20epidemiological%2C%20and%20evolutionary%20applications.%20Compared%20to%20the%20SNaPshot%20approach%2C%20the%20implementation%20of%20the%20iPLEX%20technology%20could%20offer%20a%20higher%20throughput%20and%20could%20be%20a%20more%20flexible%20and%20cost-effective%20option%20for%20microbiology%20laboratories.%22%2C%22date%22%3A%2209%5C%2F01%5C%2F2011%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2FJCM.00744-11%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjcm.asm.org%5C%2Fcontent%5C%2F49%5C%2F9%5C%2F3292%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T09%3A48%3A00Z%22%7D%7D%2C%7B%22key%22%3A%225KDL9KWM%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brossier%22%2C%22parsedDate%22%3A%222011%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBrossier%2C%20F.%20%282011%29.%20%3Cb%3EM%26%23xE9%3Bcanismes%20d%26%23x2019%3Baction%20et%20de%20r%26%23xE9%3Bsistance%20de%20l%26%23x2019%3Bisoniazide%2C%20un%20antituberculeux%20de%20premi%26%23xE8%3Bre%20ligne%3C%5C%2Fb%3E.%20Journal%20des%20Anti-Infectieux%20%3Ci%3E13%3C%5C%2Fi%3E%2C%20217%26%23x2013%3B227%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.antinf.2011.10.003%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.antinf.2011.10.003%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22M%5Cu00e9canismes%20d%5Cu2019action%20et%20de%20r%5Cu00e9sistance%20de%20l%5Cu2019isoniazide%2C%20un%20antituberculeux%20de%20premi%5Cu00e8re%20ligne%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%5D%2C%22abstractNote%22%3A%22M%5Cu00e9canismes%20d%5Cu2019action%20et%20de%20r%5Cu00e9sistance%20de%20l%5Cu2019isoniazide%2C%20un%20antituberculeux%20de%20premi%5Cu00e8re%20ligne%22%2C%22date%22%3A%222011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.antinf.2011.10.003%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.em-consulte.com%5C%2Farticle%5C%2F678308%5C%2Fmecanismes-daction-et-de-resistance-de-lisoniazide%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-01T16%3A22%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22TIVFS4BA%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brossier%20et%20al.%22%2C%22parsedDate%22%3A%222011-01-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBrossier%2C%20F.%2C%20Veziris%2C%20N.%2C%20Truffot-Pernot%2C%20C.%2C%20Jarlier%2C%20V.%20and%20Sougakoff%2C%20W.%20%282011%29.%20%3Cb%3EMolecular%20Investigation%20of%20Resistance%20to%20the%20Antituberculous%20Drug%20Ethionamide%20in%20Multidrug-Resistant%20Clinical%20Isolates%20of%20Mycobacterium%20tuberculosis%3C%5C%2Fb%3E.%20Antimicrob%20Agents%20Chemother%20%3Ci%3E55%3C%5C%2Fi%3E%2C%20355%26%23x2013%3B360%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.01030-10%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.01030-10%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20Investigation%20of%20Resistance%20to%20the%20Antituberculous%20Drug%20Ethionamide%20in%20Multidrug-Resistant%20Clinical%20Isolates%20of%20Mycobacterium%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Truffot-Pernot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Sougakoff%22%7D%5D%2C%22abstractNote%22%3A%22Ethionamide%20%28ETH%29%20needs%20to%20be%20activated%20by%20the%20mono-oxygenase%20EthA%2C%20which%20is%20regulated%20by%20EthR%2C%20in%20order%20to%20be%20active%20against%20Mycobacterium%20tuberculosis.%20The%20activated%20drug%20targets%20the%20enzyme%20InhA%2C%20which%20is%20involved%20in%20cell%20wall%20biosynthesis.%20Resistance%20to%20ETH%20has%20been%20reported%20to%20result%20from%20various%20mechanisms%2C%20including%20mutations%20altering%20EthA%5C%2FEthR%2C%20InhA%20and%20its%20promoter%2C%20the%20NADH%20dehydrogenase%20encoded%20by%20ndh%2C%20and%20the%20MshA%20enzyme%2C%20involved%20in%20mycothiol%20biosynthesis.%20We%20searched%20for%20such%20mutations%20in%2087%20clinical%20isolates%3A%2047%20ETH-resistant%20%28ETHr%29%20isolates%2C%2024%20ETH-susceptible%20%28ETHs%29%20isolates%2C%20and%2016%20isolates%20susceptible%20to%20ETH%20but%20displaying%20an%20intermediate%20proportion%20of%20resistant%20cells%20%28ETHSip%3B%20defined%20as%20%5Cu22651%25%20but%20%3C10%25%20resistant%20cells%29.%20In%2081%25%20%2838%5C%2F47%29%20of%20the%20ETHr%20isolates%2C%20we%20found%20mutations%20in%20ethA%2C%20ethR%2C%20or%20inhA%20or%20its%20promoter%2C%20which%20mostly%20corresponded%20to%20new%20alterations%20in%20ethA%20and%20ethR.%20The%209%20ETHr%20isolates%20without%20a%20mutation%20in%20these%20three%20genes%20%289%5C%2F47%2C%2019%25%29%20had%20no%20mutation%20in%20ndh%2C%20and%20a%20single%20isolate%20had%20a%20mutation%20in%20mshA.%20Of%20the%2016%20ETHSip%20isolates%2C%207%20had%20a%20mutation%20in%20ethA%2C%208%20had%20no%20detectable%20mutation%2C%20and%201%20had%20a%20mutation%20in%20mshA.%20Finally%2C%20of%20the%2024%20ETHs%20isolates%2C%2023%20had%20no%20mutation%20in%20the%20studied%20genes%20and%201%20displayed%20a%20yet%20unknown%20mutation%20in%20the%20inhA%20promoter.%20Globally%2C%20the%20mechanism%20of%20resistance%20to%20ETH%20remained%20unknown%20for%2019%25%20of%20the%20ETHr%20isolates%2C%20highlighting%20the%20complexity%20of%20the%20mechanisms%20of%20ETH%20resistance%20in%20M.%20tuberculosis.%22%2C%22date%22%3A%2201%5C%2F01%5C%2F2011%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.01030-10%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Faac.asm.org%5C%2Fcontent%5C%2F55%5C%2F1%5C%2F355%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T12%3A22%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22HPN66AVD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cambau%20and%20R%5Cu00fcsch-Gerdes%22%2C%22parsedDate%22%3A%222011-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECambau%2C%20E.%20and%20R%26%23xFC%3Bsch-Gerdes%2C%20S.%20%282011%29.%20First-%20and%20second-line%20drug%20susceptibility%20testing%20for%20Mycobacterium%20tuberculosis%20complex%2C%20ECDC%2C%20Stockholm%2C%20URL%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fop.europa.eu%5C%2Fen%5C%2Fpublication-detail%5C%2F-%5C%2Fpublication%5C%2F9803f7a5-6188-48f2-84cd-d83f0b95c0c1%5C%2Flanguage-en%27%3Ehttps%3A%5C%2F%5C%2Fop.europa.eu%5C%2Fen%5C%2Fpublication-detail%5C%2F-%5C%2Fpublication%5C%2F9803f7a5-6188-48f2-84cd-d83f0b95c0c1%5C%2Flanguage-en%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22report%22%2C%22title%22%3A%22First-%20and%20second-line%20drug%20susceptibility%20testing%20for%20Mycobacterium%20tuberculosis%20complex%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22R%5Cu00fcsch-Gerdes%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22reportNumber%22%3A%22doi%2010.2900%5C%2F39099%22%2C%22reportType%22%3A%22%22%2C%22institution%22%3A%22ECDC%22%2C%22date%22%3A%22may%202011%22%2C%22language%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fop.europa.eu%5C%2Fen%5C%2Fpublication-detail%5C%2F-%5C%2Fpublication%5C%2F9803f7a5-6188-48f2-84cd-d83f0b95c0c1%5C%2Flanguage-en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-04-02T21%3A22%3A36Z%22%7D%7D%2C%7B%22key%22%3A%223NDD3VC3%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Couderc%20et%20al.%22%2C%22parsedDate%22%3A%222011%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECouderc%2C%20C.%2C%20Carbonne%2C%20A.%2C%20Thiolet%2C%20J.%20M.%2C%20Brossier%2C%20F.%2C%20Savey%2C%20A.%2C%20Bernet%2C%20C.%2C%20Ortmans%2C%20C.%2C%20Lecadet-Morin%2C%20C.%2C%20Coudi%26%23xE8%3Bre%2C%20I.%2C%20Aggoune%2C%20M.%2C%20Astagneau%2C%20P.%2C%20Coignard%2C%20B.%20and%20Cambau%2C%20E.%20%282011%29.%20%3Cb%3EInfections%20%26%23xE0%3B%20mycobact%26%23xE9%3Bries%20atypiques%20li%26%23xE9%3Bes%20%26%23xE0%3B%20des%20soins%20esth%26%23xE9%3Btiques%20en%20France%2C%202001%26%23x2013%3B2010%3C%5C%2Fb%3E.%20M%26%23xE9%3Bdecine%20et%20Maladies%20Infectieuses%20%3Ci%3E41%3C%5C%2Fi%3E%2C%20379%26%23x2013%3B383%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2011.02.007%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2011.02.007%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Infections%20%5Cu00e0%20mycobact%5Cu00e9ries%20atypiques%20li%5Cu00e9es%20%5Cu00e0%20des%20soins%20esth%5Cu00e9tiques%20en%20France%2C%202001%5Cu20132010%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Couderc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Carbonne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.M.%22%2C%22lastName%22%3A%22Thiolet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Savey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Bernet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Ortmans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Lecadet-Morin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.%22%2C%22lastName%22%3A%22Coudi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Aggoune%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Astagneau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Coignard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%227%5C%2F2011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.medmal.2011.02.007%22%2C%22ISSN%22%3A%220399077X%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.em-consulte.com%5C%2Farticle%5C%2F284859%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T17%3A46%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22PNDATX4F%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cribier%20et%20al.%22%2C%22parsedDate%22%3A%222011-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECribier%2C%20B.%2C%20Aubry%2C%20A.%2C%20Caumes%2C%20E.%2C%20Cambau%2C%20E.%2C%20Jarlier%2C%20V.%20and%20Chosidow%2C%20O.%20%282011%29.%20%3Cb%3E%5BHistopathological%20study%20of%20Mycobacterium%20marinum%20infection%5D%3C%5C%2Fb%3E.%20Ann%20Dermatol%20Venereol%20%3Ci%3E138%3C%5C%2Fi%3E%2C%2017%26%23x2013%3B22%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.annder.2010.10.025%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.annder.2010.10.025%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22%5BHistopathological%20study%20of%20Mycobacterium%20marinum%20infection%5D%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Cribier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O%22%2C%22lastName%22%3A%22Chosidow%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Skin%20infection%20by%20Mycobacterium%20marinum%20induces%20the%20classic%20granuloma%20of%20aquariums%20and%20swimming%20pools.%20The%20histopathological%20signs%20have%20been%20described%20primarily%20in%20small%20series%20of%20typical%20cases%2C%20generally%20with%20no%20bacteriological%20evidence.%20In%20a%20national%20survey%20of%20proven%20infection%20with%20M.%20marinum%20detailed%20data%20was%20collected%20for%2063%20patients.%20The%20aim%20of%20this%20new%20study%20was%20to%20describe%20microscopic%20signs%20of%20the%20infection%20based%20upon%20biopsies%20taken%20from%20these%20patients.%5CnPATIENTS%20AND%20METHODS%3A%20Unstained%20slides%20from%2032%20biopsies%20of%20the%20skin%20%28n%3D24%29%20or%20synovial%20biopsies%20%28n%3D8%29%20were%20prepared%3B%20they%20originated%20from%2027%20patients.%20They%20were%20examined%20after%20standard%20staining%20and%20after%20Ziehl-Neelsen%20staining%2C%20without%20knowledge%20of%20the%20clinical%20data.%5CnRESULTS%3A%20All%20biopsies%20were%20taken%20from%20the%20upper%20limb%20of%2018%20men%20and%20nine%20women%20of%20mean%20age%2048%20years.%20Tubercular%20granulomas%20were%20observed%20in%20only%2060%25%20of%20cases.%20The%20largest%20and%20most%20numerous%20were%20seen%20in%20the%20synovial%20samples.%20Due%20to%20their%20palisade%20appearance%2C%20they%20were%20occasionally%20impossible%20to%20distinguish%20from%20rheumatoid%20nodules.%20In%2020%25%20of%20cases%2C%20neutrophil%20collections%20were%20seen%20without%20granulomas%20and%20in%20remaining%2020%25%20of%20cases%2C%20relatively%20non-specific%20infiltrate%20was%20observed.%20Epidermal%20changes%20consisted%20in%20psoriasiform%20or%20pseudocarcinomatous%20hyperplasia%2C%20particularly%20at%20the%20edges%20of%20ulcerated%20areas%3B%20invasion%20of%20the%20dermo-epidermal%20junction%20was%20seen%20in%20five%20cases.%20Follicular%20necrosis%20was%20observed%20in%20four%20cases%20with%20lymphoplasmacytic%20infiltrates%20remote%20from%20the%20granulomas%20being%20seen%20in%2022%20biopsies.%20Ziehl-Neelsen%20staining%20revealed%20no%20bacilli.%5CnDISCUSSION%3A%20The%20originality%20of%20this%20series%20consists%20of%20bacteriological%20proof%20of%20M.%20marinum%20infection%20and%20the%20absence%20of%20biopsy%20selection%20based%20on%20clinical%20criteria.%20It%20shows%20that%20the%20typical%20granulomas%20are%20in%20fact%20present%20in%20less%20than%20two%20third%20of%20cases%2C%20and%20that%20these%20may%20be%20confused%20with%20rheumatoid%20nodules.%20The%20chief%20characteristic%20of%20these%20lesions%20is%20the%20very%20low%20concentration%20of%20microorganisms%20present%2C%20in%20contrast%20with%20other%20forms%20of%20mycobacterium%2C%20making%20them%20difficult%20to%20see%3B%20routine%20confirmation%20cannot%20thus%20be%20expected%20from%20specific%20staining%20procedures.%20In%20one%20case%20out%20of%20five%2C%20the%20infiltrate%20suggested%20no%20infectious%20origin%2C%20although%20deep%20skin%20biopsies%20and%20synovial%20biopsies%20provided%20more%20information.%20For%20all%20forms%20of%20necrotic%20granuloma%2C%20whether%20or%20not%20accompanied%20by%20collections%20of%20neutrophils%2C%20a%20culture%20should%20be%20carried%20out%20in%20a%20specific%20medium%2C%20even%20in%20the%20absence%20of%20microscopic%20evidence%20of%20bacilli.%22%2C%22date%22%3A%22Jan%202011%22%2C%22language%22%3A%22fre%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.annder.2010.10.025%22%2C%22ISSN%22%3A%220151-9638%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T09%3A49%3A30Z%22%7D%7D%2C%7B%22key%22%3A%228IWB25CE%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fauville-Dufaux%20et%20al.%22%2C%22parsedDate%22%3A%222011-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFauville-Dufaux%2C%20M.%2C%20Jarlier%2C%20V.%2C%20van%20Soolingen%2C%20D.%20and%20Hoffner%2C%20S.%20%282011%29.%20%3Cb%3EBiosafety%20in%20the%20clinical%20laboratory%20diagnosis%20of%20tuberculosis%3C%5C%2Fb%3E.%20In%3A%20%3Cb%3EMastering%20the%20basics%20of%20TB%20control%20-%20Development%20of%20a%20handbook%20on%20TB%20diagnostic%20methods%3C%5C%2Fb%3E%2C%20ECDC%2C%20Stockholm%2C%20pp.%2011%26%23x2013%3B18%2C%20URL%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27doi%2010.2900%5C%2F39099%27%3Edoi%2010.2900%5C%2F39099%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Biosafety%20in%20the%20clinical%20laboratory%20diagnosis%20of%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Fauville-Dufaux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22van%20Soolingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Hoffner%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22bookTitle%22%3A%22Mastering%20the%20basics%20of%20TB%20control%20-%20Development%20of%20a%20handbook%20on%20TB%20diagnostic%20methods%22%2C%22date%22%3A%22may%202011%22%2C%22language%22%3A%22%22%2C%22ISBN%22%3A%22978-92-9193-242-9%22%2C%22url%22%3A%22doi%2010.2900%5C%2F39099%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-25T16%3A07%3A21Z%22%7D%7D%2C%7B%22key%22%3A%222739786Z%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lerat%20et%20al.%22%2C%22parsedDate%22%3A%222011%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELerat%2C%20I.%2C%20Truffot%2C%20C.%20and%20Veziris%2C%20N.%20%282011%29.%20%3Cb%3EInfections%20%26%23xE0%3B%20Mycobacterium%20abscessus%26%23x202F%3B%3A%20%26%23xE9%3Bpid%26%23xE9%3Bmiologie%2C%20aspects%20cliniques%20et%20traitement%3C%5C%2Fb%3E.%20Journal%20des%20Anti-infectieux%20%3Ci%3E13%3C%5C%2Fi%3E%2C%2049%26%23x2013%3B55.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Infections%20%5Cu00e0%20Mycobacterium%20abscessus%20%3A%20%5Cu00e9pid%5Cu00e9miologie%2C%20aspects%20cliniques%20et%20traitement%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I%22%2C%22lastName%22%3A%22Lerat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Truffot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T09%3A59%3A44Z%22%7D%7D%2C%7B%22key%22%3A%226PX9I7RU%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Macheras%20et%20al.%22%2C%22parsedDate%22%3A%222011-02-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMacheras%2C%20E.%2C%20Roux%2C%20A.-L.%2C%20Bastian%2C%20S.%2C%20Le%26%23xE3%3Bo%2C%20S.%20C.%2C%20Palaci%2C%20M.%2C%20Sivadon-Tardy%2C%20V.%2C%20Gutierrez%2C%20C.%2C%20Richter%2C%20E.%2C%20R%26%23xFC%3Bsch-Gerdes%2C%20S.%2C%20Pfyffer%2C%20G.%2C%20Bodmer%2C%20T.%2C%20Cambau%2C%20E.%2C%20Gaillard%2C%20J.-L.%20and%20Heym%2C%20B.%20%282011%29.%20%3Cb%3EMultilocus%20Sequence%20Analysis%20and%20rpoB%20Sequencing%20of%20Mycobacterium%20abscessus%20%28Sensu%20Lato%29%20Strains%3C%5C%2Fb%3E.%20J%20Clin%20Microbiol%20%3Ci%3E49%3C%5C%2Fi%3E%2C%20491%26%23x2013%3B499%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.01274-10%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.01274-10%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multilocus%20Sequence%20Analysis%20and%20rpoB%20Sequencing%20of%20Mycobacterium%20abscessus%20%28Sensu%20Lato%29%20Strains%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edouard%22%2C%22lastName%22%3A%22Macheras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Laure%22%2C%22lastName%22%3A%22Roux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvaine%22%2C%22lastName%22%3A%22Bastian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvia%20Cardoso%22%2C%22lastName%22%3A%22Le%5Cu00e3o%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moises%22%2C%22lastName%22%3A%22Palaci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22Sivadon-Tardy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Gutierrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elvira%22%2C%22lastName%22%3A%22Richter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabine%22%2C%22lastName%22%3A%22R%5Cu00fcsch-Gerdes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaby%22%2C%22lastName%22%3A%22Pfyffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Bodmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Louis%22%2C%22lastName%22%3A%22Gaillard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beate%22%2C%22lastName%22%3A%22Heym%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacterium%20abscessus%2C%20Mycobacterium%20bolletii%2C%20and%20Mycobacterium%20massiliense%20%28Mycobacterium%20abscessus%20sensu%20lato%29%20are%20closely%20related%20species%20that%20currently%20are%20identified%20by%20the%20sequencing%20of%20the%20rpoB%20gene.%20However%2C%20recent%20studies%20show%20that%20rpoB%20sequencing%20alone%20is%20insufficient%20to%20discriminate%20between%20these%20species%2C%20and%20some%20authors%20have%20questioned%20their%20current%20taxonomic%20classification.%20We%20studied%20here%20a%20large%20collection%20of%20M.%20abscessus%20%28sensu%20lato%29%20strains%20by%20partial%20rpoB%20sequencing%20%28752%20bp%29%20and%20multilocus%20sequence%20analysis%20%28MLSA%29.%20The%20final%20MLSA%20scheme%20developed%20was%20based%20on%20the%20partial%20sequences%20of%20eight%20housekeeping%20genes%3A%20argH%2C%20cya%2C%20glpK%2C%20gnd%2C%20murC%2C%20pgm%2C%20pta%2C%20and%20purH.%20The%20strains%20studied%20included%20the%20three%20type%20strains%20%28M.%20abscessus%20CIP%20104536T%2C%20M.%20massiliense%20CIP%20108297T%2C%20and%20M.%20bolletii%20CIP%20108541T%29%20and%20120%20isolates%20recovered%20between%201997%20and%202007%20in%20France%2C%20Germany%2C%20Switzerland%2C%20and%20Brazil.%20The%20rpoB%20phylogenetic%20tree%20confirmed%20the%20existence%20of%20three%20main%20clusters%2C%20each%20comprising%20the%20type%20strain%20of%20one%20species.%20However%2C%20divergence%20values%20between%20the%20M.%20massiliense%20and%20M.%20bolletii%20clusters%20all%20were%20below%203%25%20and%20between%20the%20M.%20abscessus%20and%20M.%20massiliense%20clusters%20were%20from%202.66%20to%203.59%25.%20The%20tree%20produced%20using%20the%20concatenated%20MLSA%20gene%20sequences%20%284%2C071%20bp%29%20also%20showed%20three%20main%20clusters%2C%20each%20comprising%20the%20type%20strain%20of%20one%20species.%20The%20M.%20abscessus%20cluster%20had%20a%20bootstrap%20value%20of%20100%25%20and%20was%20mostly%20compact.%20Bootstrap%20values%20for%20the%20M.%20massiliense%20and%20M.%20bolletii%20branches%20were%20much%20lower%20%2871%20and%2061%25%2C%20respectively%29%2C%20with%20the%20M.%20massiliense%20cluster%20having%20a%20fuzzy%20aspect.%20Mean%20%28range%29%20divergence%20values%20were%202.17%25%20%281.13%20to%202.58%25%29%20between%20the%20M.%20abscessus%20and%20M.%20massiliense%20clusters%2C%202.37%25%20%281.5%20to%202.85%25%29%20between%20the%20M.%20abscessus%20and%20M.%20bolletii%20clusters%2C%20and%202.28%25%20%280.86%20to%202.68%25%29%20between%20the%20M.%20massiliense%20and%20M.%20bolletii%20clusters.%20Adding%20the%20rpoB%20sequence%20to%20the%20MLSA-concatenated%20sequence%20%28total%20sequence%2C%204%2C823%20bp%29%20had%20little%20effect%20on%20the%20clustering%20of%20strains.%20We%20found%2010%5C%2F120%20%288.3%25%29%20isolates%20for%20which%20the%20concatenated%20MLSA%20gene%20sequence%20and%20rpoB%20sequence%20were%20discordant%20%28e.g.%2C%20M.%20massiliense%20MLSA%20sequence%20and%20M.%20abscessus%20rpoB%20sequence%29%2C%20suggesting%20the%20intergroup%20lateral%20transfers%20of%20rpoB.%20In%20conclusion%2C%20our%20study%20strongly%20supports%20the%20recent%20proposal%20that%20M.%20abscessus%2C%20M.%20massiliense%2C%20and%20M.%20bolletii%20should%20constitute%20a%20single%20species.%20Our%20findings%20also%20indicate%20that%20there%20has%20been%20a%20horizontal%20transfer%20of%20rpoB%20sequences%20between%20these%20subgroups%2C%20precluding%20the%20use%20of%20rpoB%20sequencing%20alone%20for%20the%20accurate%20identification%20of%20the%20two%20proposed%20M.%20abscessus%20subspecies.%22%2C%22date%22%3A%2202%5C%2F01%5C%2F2011%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2FJCM.01274-10%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjcm.asm.org%5C%2Fcontent%5C%2F49%5C%2F2%5C%2F491%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T09%3A49%3A16Z%22%7D%7D%2C%7B%22key%22%3A%229A43HDTV%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pantel%20et%20al.%22%2C%22parsedDate%22%3A%222011-10-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPantel%2C%20A.%2C%20Petrella%2C%20S.%2C%20Matrat%2C%20S.%2C%20Brossier%2C%20F.%2C%20Bastian%2C%20S.%2C%20Reitter%2C%20D.%2C%20Jarlier%2C%20V.%2C%20Mayer%2C%20C.%20and%20Aubry%2C%20A.%20%282011%29.%20%3Cb%3EDNA%20Gyrase%20Inhibition%20Assays%20Are%20Necessary%20To%20Demonstrate%20Fluoroquinolone%20Resistance%20Secondary%20to%20gyrB%20Mutations%20in%20Mycobacterium%20tuberculosis%3C%5C%2Fb%3E.%20Antimicrob%20Agents%20Chemother%20%3Ci%3E55%3C%5C%2Fi%3E%2C%204524%26%23x2013%3B4529%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.00707-11%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.00707-11%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22DNA%20Gyrase%20Inhibition%20Assays%20Are%20Necessary%20To%20Demonstrate%20Fluoroquinolone%20Resistance%20Secondary%20to%20gyrB%20Mutations%20in%20Mycobacterium%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alix%22%2C%22lastName%22%3A%22Pantel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Petrella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Matrat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvaine%22%2C%22lastName%22%3A%22Bastian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Delphine%22%2C%22lastName%22%3A%22Reitter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudine%22%2C%22lastName%22%3A%22Mayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22The%20main%20mechanism%20of%20fluoroquinolone%20%28FQ%29%20resistance%20in%20Mycobacterium%20tuberculosis%20is%20mutation%20in%20DNA%20gyrase%20%28GyrA2GyrB2%29%2C%20especially%20in%20gyrA.%20However%2C%20the%20discovery%20of%20unknown%20mutations%20in%20gyrB%20whose%20implication%20in%20FQ%20resistance%20is%20unclear%20has%20become%20more%20frequent.%20We%20investigated%20the%20impact%20on%20FQ%20susceptibility%20of%20eight%20gyrB%20mutations%20in%20M.%20tuberculosis%20clinical%20strains%2C%20three%20of%20which%20were%20previously%20identified%20in%20an%20FQ-resistant%20strain.%20We%20measured%20FQ%20MICs%20and%20also%20DNA%20gyrase%20inhibition%20by%20FQs%20in%20order%20to%20clarify%20the%20role%20of%20these%20mutations%20in%20FQ%20resistance.%20Wild-type%20GyrA%2C%20wild-type%20GyrB%2C%20and%20mutant%20GyrB%20subunits%20produced%20from%20engineered%20gyrB%20alleles%20by%20mutagenesis%20were%20overexpressed%20in%20Escherichia%20coli%2C%20purified%20to%20homogeneity%2C%20and%20used%20to%20reconstitute%20highly%20active%20gyrase%20complexes.%20MICs%20and%20DNA%20gyrase%20inhibition%20were%20determined%20for%20moxifloxacin%2C%20gatifloxacin%2C%20ofloxacin%2C%20levofloxacin%2C%20and%20enoxacin.%20We%20demonstrated%20that%20the%20eight%20substitutions%20in%20GyrB%20%28D473N%2C%20P478A%2C%20R485H%2C%20S486F%2C%20A506G%2C%20A547V%2C%20G551R%2C%20and%20G559A%29%2C%20recently%20identified%20in%20FQ-resistant%20clinical%20strains%20or%20encountered%20in%20M.%20tuberculosis%20strains%20isolated%20in%20France%2C%20are%20not%20implicated%20in%20FQ%20resistance.%20These%20results%20underline%20that%2C%20as%20opposed%20to%20phenotypic%20FQ%20susceptibility%20testing%2C%20the%20DNA%20gyrase%20inhibition%20assay%20is%20the%20only%20way%20to%20prove%20the%20role%20of%20a%20DNA%20gyrase%20mutation%20in%20FQ%20resistance.%20Therefore%2C%20the%20use%20of%20FQ%20in%20the%20treatment%20of%20tuberculosis%20%28TB%29%20patients%20should%20not%20be%20ruled%20out%20only%20on%20the%20basis%20of%20the%20presence%20of%20mutations%20in%20gyrB.%22%2C%22date%22%3A%2210%5C%2F01%5C%2F2011%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.00707-11%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Faac.asm.org%5C%2Fcontent%5C%2F55%5C%2F10%5C%2F4524%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A57%3A57Z%22%7D%7D%2C%7B%22key%22%3A%226RTU8WMI%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Petrella%20et%20al.%22%2C%22parsedDate%22%3A%222011-01-24%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPetrella%2C%20S.%2C%20Gelus-Ziental%2C%20N.%2C%20Maudry%2C%20A.%2C%20Laurans%2C%20C.%2C%20Boudjelloul%2C%20R.%20and%20Sougakoff%2C%20W.%20%282011%29.%20%3Cb%3ECrystal%20Structure%20of%20the%20Pyrazinamidase%20of%20Mycobacterium%20tuberculosis%26%23x202F%3B%3A%20Insights%20into%20Natural%20and%20Acquired%20Resistance%20to%20Pyrazinamide%3C%5C%2Fb%3E.%20PLOS%20ONE%20%3Ci%3E6%3C%5C%2Fi%3E%2C%20e15785%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0015785%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0015785%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Crystal%20Structure%20of%20the%20Pyrazinamidase%20of%20Mycobacterium%20tuberculosis%20%3A%20Insights%20into%20Natural%20and%20Acquired%20Resistance%20to%20Pyrazinamide%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Petrella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Gelus-Ziental%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnaud%22%2C%22lastName%22%3A%22Maudry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Laurans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachid%22%2C%22lastName%22%3A%22Boudjelloul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%5D%2C%22abstractNote%22%3A%22Pyrazinamidase%20%28PncA%29%20activates%20the%20first-line%20antituberculous%20drug%20pyrazinamide%20into%20pyrazinoic%20acid.%20The%20crystal%20structure%20of%20the%20%20Mycobacterium%20tuberculosis%20%20PncA%20protein%20has%20been%20determined%2C%20showing%20significant%20differences%20in%20the%20substrate%20binding%20cavity%20when%20compared%20to%20the%20pyrazinamidases%20from%20%20Pyrococcus%20horikoshii%20%20and%20%20Acinetobacter%20baumanii%20.%20In%20%20M.%20tuberculosis%20%2C%20this%20region%20was%20found%20to%20hold%20a%20Fe%202%2B%20%20ion%20coordinated%20by%20one%20aspartate%20and%20three%20histidines%2C%20one%20of%20them%20corresponding%20to%20His57%20which%20is%20replaced%20by%20Asp%20in%20%20Mycobacterium%20bovis%20%2C%20a%20species%20naturally%20resistant%20to%20pyrazinamide.%20The%20binding%20cavity%20also%20contains%20a%20Cys138-Asp8-Lys96%20motif%20evocating%20a%20cysteine-based%20catalytic%20mechanism.%20Mutants%20have%20been%20constructed%20and%20investigated%20by%20kinetic%20and%20thermal%20shift%20assays%2C%20highlighting%20the%20importance%20of%20protein%20folding%20and%20thermal%20stability%20in%20the%20pyrazinamidase%20activity.%22%2C%22date%22%3A%2224%20janv.%202011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0015785%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjournals.plos.org%5C%2Fplosone%5C%2Farticle%3Fid%3D10.1371%5C%2Fjournal.pone.0015785%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-25T05%3A39%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22VTXFK3VD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Prevotat%20et%20al.%22%2C%22parsedDate%22%3A%222011-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPrevotat%2C%20A.%2C%20Bonne%2C%20S.%2C%20Veziris%2C%20N.%2C%20Senneville%2C%20E.%2C%20Yazdanpanah%2C%20Y.%20and%20Legout%2C%20L.%20%282011%29.%20%3Cb%3E%5BMycobacterium%20abscessus%20pulmonary%20infection%20treated%20with%20tigecyclin-amikacin%20and%20cefoxitin%20in%20a%20diabetic%20patient%5D%3C%5C%2Fb%3E.%20Med%20Mal%20Infect%20%3Ci%3E41%3C%5C%2Fi%3E%2C%20446%26%23x2013%3B448%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2011.02.011%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2011.02.011%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22%5BMycobacterium%20abscessus%20pulmonary%20infection%20treated%20with%20tigecyclin-amikacin%20and%20cefoxitin%20in%20a%20diabetic%20patient%5D%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Prevotat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22Bonne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Senneville%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y%22%2C%22lastName%22%3A%22Yazdanpanah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%22%2C%22lastName%22%3A%22Legout%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Aug%202011%22%2C%22language%22%3A%22fre%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.medmal.2011.02.011%22%2C%22ISSN%22%3A%221769-6690%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T09%3A49%3A56Z%22%7D%7D%2C%7B%22key%22%3A%222T94ZQUC%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Radomski%20et%20al.%22%2C%22parsedDate%22%3A%222011-06-15%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ERadomski%2C%20N.%2C%20Betelli%2C%20L.%2C%20Moilleron%2C%20R.%2C%20Haenn%2C%20S.%2C%20Moulin%2C%20L.%2C%20Cambau%2C%20E.%2C%20Rocher%2C%20V.%2C%20Gon%26%23xE7%3Balves%2C%20A.%20and%20Lucas%2C%20F.%20S.%20%282011%29.%20%3Cb%3EMycobacterium%20Behavior%20in%20Wastewater%20Treatment%20Plant%2C%20A%20Bacterial%20Model%20Distinct%20From%20Escherichia%20coli%20and%20Enterococci%3C%5C%2Fb%3E.%20Environ%20Sci%20Technol%20%3Ci%3E45%3C%5C%2Fi%3E%2C%205380%26%23x2013%3B5386%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Fes104084c%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Fes104084c%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mycobacterium%20Behavior%20in%20Wastewater%20Treatment%20Plant%2C%20A%20Bacterial%20Model%20Distinct%20From%20Escherichia%20coli%20and%20Enterococci%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Radomski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laetitia%22%2C%22lastName%22%3A%22Betelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%5Cu00e9gis%22%2C%22lastName%22%3A%22Moilleron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Haenn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Moulin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Rocher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Gon%5Cu00e7alves%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%20S.%22%2C%22lastName%22%3A%22Lucas%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacteria%20are%20waterborne%20emerging%20pathogens%20causing%20infections%20in%20human.%20Mycobacteria%20have%20been%20previously%20isolated%20from%20wastewater%20and%20sludge%2C%20but%20their%20densities%20were%20not%20estimated%20due%20to%20cultural%20biases.%20In%20order%20to%20evaluate%20the%20impact%20of%20wastewater%20treatment%20processes%20on%20mycobacteria%20removal%2C%20we%20used%20a%20real%20time%20PCR%20method.%20First%20we%20compared%20six%20DNA%20extraction%20methods%20and%20second%20we%20used%20the%20more%20efficient%20DNA%20extraction%20procedure%20%28i.e.%2C%20enzymatic%20lysis%20combined%20with%20hexadecyltrimethylammonium%20bromide-NaCl%20procedure%29%20in%20order%20to%20quantify%20Mycobacterium.%20With%20the%20aim%20to%20identify%20parameters%20that%20could%20serve%20as%20indicator%20of%20mycobacterial%20behavior%2C%20mycobacterial%20densities%20were%20measured%20in%20parallel%20to%20those%20of%20Escherichia%20coli%20and%20enterococci%2C%20and%20to%20concentrations%20of%20chemical%20parameters%20usually%20monitored%20in%20wastewater.%20Mycobacterium%20reached%205.5%20%3F%20105%20%5Cu00b1%203.9%20%3F%20105%20copies%5C%2FL%20in%20the%20influent%2C%20but%20was%20not%20detected%20in%20the%20effluent%20after%20decantation%20and%20biofiltration.%20Most%20mycobacteria%20%2898.6%20%5Cu00b1%202.7%25%2C%20i.e.%202.4%20%5Cu00b1%200.7%20log10%29%20were%20removed%20by%20the%20physical%3Fchemical%20decantation%2C%20and%20the%20remaining%20mycobacteria%20were%20removed%20by%20biofiltration.%20In%20contrast%2C%20enterococci%20and%20E.%20coli%20were%20lightly%20removed%20by%20decantation%20step%20and%20mainly%20removed%20by%20biofiltration.%20Our%20results%20showed%20that%20Mycobacterium%20corresponds%20to%20a%20hydrophobic%20behavior%20linked%20to%20insoluble%20compound%20removal%2C%20whereas%20enterococci%20and%20E.%20coli%20refer%20to%20hydrophilic%20behaviors%20linked%20to%20soluble%20compound%20removals.%22%2C%22date%22%3A%22June%2015%2C%202011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1021%5C%2Fes104084c%22%2C%22ISSN%22%3A%220013-936X%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fdx.doi.org%5C%2F10.1021%5C%2Fes104084c%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222014-07-23T15%3A17%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22FTZQAWT6%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Schneider%20et%20al.%22%2C%22parsedDate%22%3A%222011-03-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESchneider%2C%20P.%2C%20Monsel%2C%20G.%2C%20Veziris%2C%20N.%2C%20Roujeau%2C%20J.-C.%2C%20Bricaire%2C%20F.%20and%20Caumes%2C%20E.%20%282011%29.%20%3Cb%3ESuccessful%20treatment%20of%20nodular%20lymphangitis%20due%20to%20in%20two%20immunosuppressed%20patients%3C%5C%2Fb%3E.%20Dermatology%20Online%20Journal%20%3Ci%3E17%3C%5C%2Fi%3E%2C%20URL%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fescholarship.org%5C%2Fuc%5C%2Fitem%5C%2F8f55s44k%27%3Ehttp%3A%5C%2F%5C%2Fescholarship.org%5C%2Fuc%5C%2Fitem%5C%2F8f55s44k%3C%5C%2Fa%3E%20%5BAccessed%20September%202013%5D.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Successful%20treatment%20of%20nodular%20lymphangitis%20due%20to%20in%20two%20immunosuppressed%20patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Schneider%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gentiane%22%2C%22lastName%22%3A%22Monsel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Claude%22%2C%22lastName%22%3A%22Roujeau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Bricaire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Caumes%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222011-03-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fescholarship.org%5C%2Fuc%5C%2Fitem%5C%2F8f55s44k%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T09%3A50%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22WRKZ2D44%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sougakoff%22%2C%22parsedDate%22%3A%222011-06-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESougakoff%2C%20W.%20%282011%29.%20%3Cb%3EMolecular%20epidemiology%20of%20multidrug-resistant%20strains%20of%20Mycobacterium%20tuberculosis%3C%5C%2Fb%3E.%20Clinical%20Microbiology%20and%20Infection%20%3Ci%3E17%3C%5C%2Fi%3E%2C%20800%26%23x2013%3B805%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fj.1469-0691.2011.03577.x%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fj.1469-0691.2011.03577.x%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20epidemiology%20of%20multidrug-resistant%20strains%20of%20Mycobacterium%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Sougakoff%22%7D%5D%2C%22abstractNote%22%3A%22Genotyping%20of%20Mycobacterium%20tuberculosis%20has%20been%20extensively%20used%20for%20investigating%20epidemics%20of%20multidrug-resistant%20strains%20of%20M.%20tuberculosis%2C%20in%20order%20to%20identify%20the%20factors%20involved%20in%20the%20transmission%20of%20such%20strains%20and%20determine%20effective%20control%20programmes%20to%20limit%20their%20expansion%20at%20both%20the%20individual%20and%20population%20levels.%20Here%2C%20we%20review%20the%20methods%20currently%20used%20to%20study%20the%20molecular%20epidemiology%20of%20multidrug-resistant%20M.%20tuberculosis%20strains%2C%20and%20the%20insights%20provided%20by%20these%20techniques%20regarding%20global%20trends%20and%20the%20transmission%20dynamics%20of%20multidrug-resistant%20tuberculosis%20at%20a%20world%20scale.%22%2C%22date%22%3A%222011%5C%2F06%5C%2F01%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1111%5C%2Fj.1469-0691.2011.03577.x%22%2C%22ISSN%22%3A%221198-743X%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.clinicalmicrobiologyandinfection.com%5C%2Farticle%5C%2FS1198743X1461973X%5C%2Fabstract%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-25T05%3A44%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22QVVIQIUT%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tochon%20et%20al.%22%2C%22parsedDate%22%3A%222011-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ETochon%2C%20M.%2C%20Bosdure%2C%20E.%2C%20Salles%2C%20M.%2C%20Beloncle%2C%20C.%2C%20Chadelat%2C%20K.%2C%20Dagorne%2C%20M.%2C%20Gaudelus%2C%20J.%2C%20Losi%2C%20S.%2C%20Renoux%2C%20M.%20C.%2C%20Veziris%2C%20N.%20and%20Dubus%2C%20J.%20C.%20%282011%29.%20%3Cb%3EManagement%20of%20young%20children%20in%20contact%20with%20an%20adult%20with%20drug-resistant%20tuberculosis%2C%20France%2C%202004-2008%3C%5C%2Fb%3E.%20Int%20J%20Tuberc%20Lung%20Dis%20%3Ci%3E15%3C%5C%2Fi%3E%2C%20326%26%23x2013%3B330.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Management%20of%20young%20children%20in%20contact%20with%20an%20adult%20with%20drug-resistant%20tuberculosis%2C%20France%2C%202004-2008%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Tochon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Bosdure%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Salles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Beloncle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K%22%2C%22lastName%22%3A%22Chadelat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Dagorne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Gaudelus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22Losi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%20C%22%2C%22lastName%22%3A%22Renoux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%20C%22%2C%22lastName%22%3A%22Dubus%22%7D%5D%2C%22abstractNote%22%3A%22SETTING%3A%20Drug-resistant%20tuberculosis%20%28DR-TB%29%20is%20increasing%20worldwide%20and%20may%20be%20a%20source%20of%20diagnostic%20and%20therapeutic%20problems%20in%20young%20exposed%20children.%20In%20France%20exposed%20children%20are%20systematically%20treated%20with%203-month%20isoniazid-rifampicin%20prophylaxis.%5CnOBJECTIVE%3A%20To%20describe%20the%20characteristics%20and%20management%20of%20children%20aged%20%3C2%20years%20in%20contact%20with%20an%20adult%20case%20of%20DR-TB%20in%20France%20over%20a%205-year%20period%20%282004-2008%29.%5CnMETHODS%3A%20Children%20were%20retrospectively%20identified%20by%20sending%20questionnaires%20to%20all%20the%20members%20of%20the%20Paediatric%20Infectious%20Diseases%20Group%20and%20the%20Paediatric%20Pulmonology%20Group%20of%20the%20French%20Paediatric%20Society.%5CnRESULTS%3A%20Ten%20children%2C%20all%20infants%2C%20in%20contact%20with%20an%20adult%20case%20of%20DR-TB%20were%20identified%3A%20six%20cases%20of%20DR-TB%20%28mean%20age%204.6%20months%29%2C%20one%20case%20of%20TB%20infection%20and%20three%20cases%20of%20exposure%20%28mean%20age%203.1%20months%29.%20The%20children%20were%20mainly%20in%20contact%20with%20poly-%20or%20multidrug-resistant%20TB.%20Time%20to%20initiation%20of%20appropriate%20treatment%20was%2039%20days%20for%20TB%20disease%20and%2058%20days%20for%20TB%20infection%20or%20exposure.%20One%20child%20with%20TB%20infection%20developed%20TB%20disease%20due%20to%20failure%20to%20adapt%20prophylaxis.%20Treatment%20was%20variable%20and%20centre-dependent.%20Short-term%20follow-up%20showed%20complete%20recovery%20of%20all%20children.%5CnCONCLUSION%3A%20Management%20of%20young%20children%20in%20contact%20with%20adult%20DR-TB%20requires%20rapid%20identification%20of%20the%20drug%20resistance%20profile.%20Molecular%20techniques%20should%20be%20used%20to%20reduce%20delays%20in%20initiating%20appropriate%20treatment.%22%2C%22date%22%3A%22Mar%202011%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221815-7920%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T09%3A49%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22ANSJTFJD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Truffot-Pernot%20and%20Veziris%22%2C%22parsedDate%22%3A%222011-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ETruffot-Pernot%2C%20C.%20and%20Veziris%2C%20N.%20%282011%29.%20%3Cb%3ELes%20tests%20bact%26%23xE9%3Briologiques%20de%20la%20tuberculose%20maladie%26%23xA0%3B%3A%20standards%20et%20perspectives%3C%5C%2Fb%3E.%20Revue%20des%20Maladies%20Respiratoires%20%3Ci%3E28%3C%5C%2Fi%3E%2C%201034%26%23x2013%3B1047%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2011.07.002%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2011.07.002%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Les%20tests%20bact%5Cu00e9riologiques%20de%20la%20tuberculose%20maladie%5Cu00a0%3A%20standards%20et%20perspectives%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Truffot-Pernot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22R%5Cu00e9sum%5Cu00e9%5CnCette%20revue%20pr%5Cu00e9sente%20les%20nouveaux%20d%5Cu00e9veloppements%20du%20diagnostic%20bact%5Cu00e9riologique%20de%20la%20tuberculose%20maladie.%20Elle%20traite%20essentiellement%20des%20techniques%20mol%5Cu00e9culaires.%20Elle%20d%5Cu00e9crit%20leurs%20performances%20et%20commente%20leur%20int%5Cu00e9gration%20dans%20le%20diagnostic%20traditionnel.%20La%20microscopie%20et%20la%20culture%20restent%20essentielles%20pour%20le%20diagnostic%20et%20les%20prises%20de%20d%5Cu00e9cision%20th%5Cu00e9rapeutique.%20Les%20outils%20mol%5Cu00e9culaires%20permettent%20d%5Cu2019acc%5Cu00e9l%5Cu00e9rer%20efficacement%20l%5Cu2019identification%20%28amplification%20g%5Cu00e9nique%29%20et%20la%20mesure%20de%20la%20sensibilit%5Cu00e9%20aux%20antituberculeux%20%28recherche%20de%20mutations%20par%20hybridation%20sur%20bandelettes%29%20des%20mycobact%5Cu00e9ries%20vues%20%5Cu00e0%20l%5Cu2019examen%20microscopique%20et%20des%20mycobact%5Cu00e9ries%20en%20culture.%20Ils%20permettent%20aussi%20de%20comparer%20efficacement%20les%20souches%20entre%20elles%20%28g%5Cu00e9notypage%29.%20En%20revanche%2C%20%5Cu00e0%20ce%20jour%2C%20ils%20ne%20sont%20toujours%20pas%20pertinents%20pour%20le%20diagnostic%20de%20la%20tuberculose%20maladie%20%5Cu00e0%20examen%20microscopique%20n%5Cu00e9gatif%20et%2C%20a%20fortiori%2C%20pour%20celui%20de%20la%20tuberculose%20%5Cu00e0%20culture%20n%5Cu00e9gative.%20La%20recherche%20d%5Cu2019anticorps%20s%5Cu00e9riques%20n%5Cu2019a%20pas%20d%5Cu2019int%5Cu00e9r%5Cu00eat%20et%20il%20serait%20imprudent%20d%5Cu2019utiliser%20les%20tests%20de%20production%20d%5Cu2019interf%5Cu00e9ron%20tels%20qu%5Cu2019ils%20sont%20pratiqu%5Cu00e9s%20aujourd%5Cu2019hui.%20De%20gros%20progr%5Cu00e8s%20ont%20%5Cu00e9t%5Cu00e9%20faits%20mais%20des%20tests%20plus%20sensibles%20sont%20encore%20attendus.%5CnSummary%5CnThis%20review%20describes%20current%20developments%20for%20the%20bacteriological%20diagnosis%20of%20active%20tuberculosis.%20It%20deals%20mainly%20with%20molecular%20methods%2C%20describing%20their%20performance%20and%20how%20they%20can%20be%20integrated%20into%20more%20traditional%20diagnostic%20approaches.%20At%20present%2C%20microscopic%20examination%20and%20culture%20are%20still%20essential%20for%20the%20diagnosis%20of%20TB%20and%20to%20guide%20therapeutic%20decisions.%20Nucleic%20acid%20amplification%20and%20line%20probe%20assays%20speed%20up%20the%20identification%20and%20susceptibility%20testing%20of%20mycobacteria%20in%20AFB%20smear%20positive%20specimens%20or%20in%20culture.%20They%20are%20also%20efficient%20for%20comparison%20of%20M.%5Cu00a0tuberculosis%20strains%20with%20each%20other%20%28genotyping%29.%20On%20the%20other%20hand%2C%20at%20present%2C%20molecular%20tests%20are%20not%20applicable%20for%20diagnosis%20in%20smear%20negative%20specimens%20and%20even%20less%20so%20for%20diagnosis%20of%20culture-negative%20tuberculosis.%20The%20use%20of%20serology%20for%20antibody%5C%2Fantigen%20detection%20is%20not%20useful%20and%20it%20is%20not%20appropriate%20to%20assays%20based%20on%20the%20release%20of%20interferon-%5Cu03b3%20release%20as%20they%20are%20currently%20available.%20Notable%20progress%20has%20been%20made%20but%20more%20sensitive%20diagnostic%20tests%20for%20TB%20are%20still%20urgently%20needed.%22%2C%22date%22%3A%22October%202011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.rmr.2011.07.002%22%2C%22ISSN%22%3A%220761-8425%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0761842511002920%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T12%3A28%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22MNEQ52UC%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22van%20Soolingen%20et%20al.%22%2C%22parsedDate%22%3A%222011-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3Evan%20Soolingen%2C%20D.%2C%20Jarlier%2C%20V.%20and%20Drobniewski%2C%20F.%20%282011%29.%20%3Cb%3EInformation%20for%20physicians%3A%20the%20laboratory%20diagnosis%20of%20tuberculosis%20%26%23x2013%3B%20first%20steps%3C%5C%2Fb%3E.%20In%3A%20%3Cb%3EMastering%20the%20basics%20of%20TB%20control%20-%20Development%20of%20a%20handbook%20on%20TB%20diagnostic%20methods%3C%5C%2Fb%3E%2C%20ECDC%2C%20Stockholm%2C%20pp.%2096%26%23x2013%3B99%2C%20URL%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27doi%2010.2900%5C%2F39099%27%3Edoi%2010.2900%5C%2F39099%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Information%20for%20physicians%3A%20the%20laboratory%20diagnosis%20of%20tuberculosis%20%5Cu2013%20first%20steps%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22van%20Soolingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%22%2C%22lastName%22%3A%22Drobniewski%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22bookTitle%22%3A%22Mastering%20the%20basics%20of%20TB%20control%20-%20Development%20of%20a%20handbook%20on%20TB%20diagnostic%20methods%22%2C%22date%22%3A%22may%202011%22%2C%22language%22%3A%22%22%2C%22ISBN%22%3A%22978-92-9193-242-9%22%2C%22url%22%3A%22doi%2010.2900%5C%2F39099%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-25T16%3A07%3A47Z%22%7D%7D%2C%7B%22key%22%3A%228UZECT6E%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Veziris%20et%20al.%22%2C%22parsedDate%22%3A%222011-03-14%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EVeziris%2C%20N.%2C%20Truffot%2C%20C.%2C%20Mainardi%2C%20J.-L.%20and%20Jarlier%2C%20V.%20%282011%29.%20%3Cb%3EActivity%20of%20carbapenems%20combined%20with%20clavulanate%20in%20murine%20tuberculosis%3C%5C%2Fb%3E.%20Antimicrob%20Agents%20Chemother%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.01824-10%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.01824-10%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Activity%20of%20carbapenems%20combined%20with%20clavulanate%20in%20murine%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chantal%22%2C%22lastName%22%3A%22Truffot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Luc%22%2C%22lastName%22%3A%22Mainardi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%5D%2C%22abstractNote%22%3A%22Although%20beta-lactam%20antibiotics%20are%20not%20considered%20as%20antituberculous%20drugs%2C%20it%20has%20been%20recently%20shown%20that%20combination%20of%20carbapenems%20and%20clavulanate%20is%20bactericidal%20in%20vitro.%20We%20evaluated%20in%20a%20murine%20model%20of%20tuberculosis%20the%20activity%20of%20carbapenems%20alone%20and%20combined%20with%20clavulanate%20against%20M.%20tuberculosis.%20Swiss%20mice%20infected%20intravenously%20with%203.105%20M.%20tuberculosis%20H37Rv%20were%20treated%20for%204%20weeks%20with%20clavulanate%20alone%20or%20imipenem%2C%20meropenem%20and%20ertapenem%20alone%20or%20combined%20with%20clavulanate%20whereas%20a%20positive%20control%20group%20was%20treated%20with%20isoniazid%20and%20a%20negative%20control%20group%20was%20held%20without%20treatment.%20The%20combination%20of%20imipenem%20or%20meropenem%20plus%20clavulanate%20significantly%20improved%20survival.%20Among%20groups%20of%20mice%20with%20100%25%20survival%2C%20only%20isoniazid%20reduced%20lung%20CFU%20counts%2C%20the%20carbapenem%2Bclavulanate%20combinations%20did%20not%20prevent%20bacterial%20growth.%20Although%20less%20active%20than%20isoniazid%2C%20the%20combinations%20of%20imipenem%20or%20meropenem%20plus%20clavulanate%20improve%20survival%20of%20mice%20infected%20with%20M.%20tuberculosis%20and%20should%20be%20further%20evaluated.%22%2C%22date%22%3A%222011-03-14%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.01824-10%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Faac.asm.org%5C%2Fcontent%5C%2Fearly%5C%2F2011%5C%2F03%5C%2F14%5C%2FAAC.01824-10%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T12%3A16%3A24Z%22%7D%7D%2C%7B%22key%22%3A%224WSEKTGJ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Veziris%20et%20al.%22%2C%22parsedDate%22%3A%222011-03-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EVeziris%2C%20N.%2C%20Ibrahim%2C%20M.%2C%20Lounis%2C%20N.%2C%20Andries%2C%20K.%20and%20Jarlier%2C%20V.%20%282011%29.%20%3Cb%3ESterilizing%20Activity%20of%20Second-Line%20Regimens%20Containing%20TMC207%20in%20a%20Murine%20Model%20of%20Tuberculosis%3C%5C%2Fb%3E.%20PLoS%20ONE%20%3Ci%3E6%3C%5C%2Fi%3E%2C%20e17556%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0017556%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0017556%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sterilizing%20Activity%20of%20Second-Line%20Regimens%20Containing%20TMC207%20in%20a%20Murine%20Model%20of%20Tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murad%22%2C%22lastName%22%3A%22Ibrahim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nacer%22%2C%22lastName%22%3A%22Lounis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Koen%22%2C%22lastName%22%3A%22Andries%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%5D%2C%22abstractNote%22%3A%22Rationale%5CnThe%20sterilizing%20activity%20of%20the%20regimen%20used%20to%20treat%20multidrug%20resistant%20tuberculosis%20%28MDR%20TB%29%20has%20not%20been%20studied%20in%20a%20mouse%20model.%5Cn%5Cn%5CnObjective%20and%20Methods%5CnSwiss%20mice%20were%20intravenously%20inoculated%20with%206%20log10%20of%20Mycobacterium%20tuberculosis%20%28TB%29%20strain%20H37Rv%2C%20treated%20with%20second-line%20drug%20combinations%20with%20or%20without%20the%20diarylquinoline%20TMC207%2C%20and%20then%20followed%20without%20treatment%20for%203%20more%20months%20to%20determine%20relapse%20rates%20%28modified%20Cornell%20model%29.%5Cn%5Cn%5CnMeasurements%5CnBactericidal%20efficacy%20was%20assessed%20by%20quantitative%20lung%20colony-forming%20unit%20%28CFU%29%20counts.%20Sterilizing%20efficacy%20was%20assessed%20by%20measuring%20bacteriological%20relapse%20rates%203%20months%20after%20the%20end%20of%20treatment.%5Cn%5Cn%5CnMain%20Results%5CnThe%20relapse%20rate%20observed%20after%2012%20months%20treatment%20with%20the%20WHO%20recommended%20MDR%20TB%20regimen%20%28amikacin%2C%20ethionamide%2C%20pyrazinamide%20and%20moxifloxacin%29%20was%20equivalent%20to%20the%20relapse%20rate%20observed%20after%206%20months%20treatment%20with%20the%20recommended%20drug%20susceptible%20TB%20regimen%20%28rifampin%2C%20isoniazid%20and%20pyrazinamide%29.%20When%20TMC207%20was%20added%20to%20this%20MDR%20TB%20regimen%2C%20the%20treatment%20duration%20needed%20to%20reach%20the%20same%20relapse%20rate%20dropped%20to%206%20months.%20A%20similar%20relapse%20rate%20was%20also%20obtained%20with%20a%206-month%20completely%20oral%20regimen%20including%20TMC207%2C%20moxifloxacin%20and%20pyrazinamide%20but%20excluding%20both%20amikacin%20and%20ethionamide.%5Cn%5Cn%5CnConclusions%5CnIn%20this%20murine%20model%20the%20duration%20of%20the%20WHO%20MDR%20TB%20treatment%20could%20be%20reduced%20to%2012%20months%20instead%20of%20the%20recommended%2018%5Cu201324%20months.%20The%20inclusion%20of%20TMC207%20in%20the%20WHO%20MDR%20TB%20treatment%20regimen%20has%20the%20potential%20to%20further%20shorten%20the%20treatment%20duration%20and%20at%20the%20same%20time%20to%20simplify%20treatment%20by%20eliminating%20the%20need%20to%20include%20an%20injectable%20aminoglycoside.%22%2C%22date%22%3A%22March%203%2C%202011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0017556%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fdx.doi.org%5C%2F10.1371%5C%2Fjournal.pone.0017556%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T09%3A48%3A37Z%22%7D%7D%5D%7D
Ali, M. A., Bastian, S., Ismail, R., Choon, T. S., Ali, S., Aubry, A., Pandian, S., Saraswat, P., Singh, A. and Gaur, R. (2011). Discovery of novel methanone derivatives acting as antimycobacterial agents. Journal of Enzyme Inhibition and Medicinal Chemistry 26, 890–894, http://doi.org/10.3109/14756366.2011.559945.
Antoun, F. and Veziris, N. (2011). Gestion des tuberculoses multirésistantes. Revue des Maladies Respiratoires 28, 956–957, http://doi.org/10.1016/j.rmr.2011.06.010.
Bastian, S., Veziris, N., Roux, A.-L., Brossier, F., Gaillard, J.-L., Jarlier, V. and Cambau, E. (2011). Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing. Antimicrob Agents Chemother 55, 775–781, http://doi.org/10.1128/AAC.00861-10.
Bouakaze, C., Keyser, C., Gonzalez, A., Sougakoff, W., Veziris, N., Dabernat, H., Jaulhac, B. and Ludes, B. (2011). Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Single Nucleotide Polymorphism Genotyping Assay Using iPLEX Gold Technology for Identification of Mycobacterium tuberculosis Complex Species and Lineages. J Clin Microbiol 49, 3292–3299, http://doi.org/10.1128/JCM.00744-11.
Brossier, F. (2011). Mécanismes d’action et de résistance de l’isoniazide, un antituberculeux de première ligne. Journal des Anti-Infectieux 13, 217–227, http://doi.org/10.1016/j.antinf.2011.10.003.
Brossier, F., Veziris, N., Truffot-Pernot, C., Jarlier, V. and Sougakoff, W. (2011). Molecular Investigation of Resistance to the Antituberculous Drug Ethionamide in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 55, 355–360, http://doi.org/10.1128/AAC.01030-10.
Cambau, E. and Rüsch-Gerdes, S. (2011). First- and second-line drug susceptibility testing for Mycobacterium tuberculosis complex, ECDC, Stockholm, URL: https://op.europa.eu/en/publication-detail/-/publication/9803f7a5-6188-48f2-84cd-d83f0b95c0c1/language-en.
Couderc, C., Carbonne, A., Thiolet, J. M., Brossier, F., Savey, A., Bernet, C., Ortmans, C., Lecadet-Morin, C., Coudière, I., Aggoune, M., Astagneau, P., Coignard, B. and Cambau, E. (2011). Infections à mycobactéries atypiques liées à des soins esthétiques en France, 2001–2010. Médecine et Maladies Infectieuses 41, 379–383, http://doi.org/10.1016/j.medmal.2011.02.007.
Cribier, B., Aubry, A., Caumes, E., Cambau, E., Jarlier, V. and Chosidow, O. (2011). [Histopathological study of Mycobacterium marinum infection]. Ann Dermatol Venereol 138, 17–22, http://doi.org/10.1016/j.annder.2010.10.025.
Fauville-Dufaux, M., Jarlier, V., van Soolingen, D. and Hoffner, S. (2011). Biosafety in the clinical laboratory diagnosis of tuberculosis. In: Mastering the basics of TB control - Development of a handbook on TB diagnostic methods, ECDC, Stockholm, pp. 11–18, URL: doi 10.2900/39099.
Lerat, I., Truffot, C. and Veziris, N. (2011). Infections à Mycobacterium abscessus : épidémiologie, aspects cliniques et traitement. Journal des Anti-infectieux 13, 49–55.
Macheras, E., Roux, A.-L., Bastian, S., Leão, S. C., Palaci, M., Sivadon-Tardy, V., Gutierrez, C., Richter, E., Rüsch-Gerdes, S., Pfyffer, G., Bodmer, T., Cambau, E., Gaillard, J.-L. and Heym, B. (2011). Multilocus Sequence Analysis and rpoB Sequencing of Mycobacterium abscessus (Sensu Lato) Strains. J Clin Microbiol 49, 491–499, http://doi.org/10.1128/JCM.01274-10.
Pantel, A., Petrella, S., Matrat, S., Brossier, F., Bastian, S., Reitter, D., Jarlier, V., Mayer, C. and Aubry, A. (2011). DNA Gyrase Inhibition Assays Are Necessary To Demonstrate Fluoroquinolone Resistance Secondary to gyrB Mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother 55, 4524–4529, http://doi.org/10.1128/AAC.00707-11.
Petrella, S., Gelus-Ziental, N., Maudry, A., Laurans, C., Boudjelloul, R. and Sougakoff, W. (2011). Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis : Insights into Natural and Acquired Resistance to Pyrazinamide. PLOS ONE 6, e15785, http://doi.org/10.1371/journal.pone.0015785.
Prevotat, A., Bonne, S., Veziris, N., Senneville, E., Yazdanpanah, Y. and Legout, L. (2011). [Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient]. Med Mal Infect 41, 446–448, http://doi.org/10.1016/j.medmal.2011.02.011.
Radomski, N., Betelli, L., Moilleron, R., Haenn, S., Moulin, L., Cambau, E., Rocher, V., Gonçalves, A. and Lucas, F. S. (2011). Mycobacterium Behavior in Wastewater Treatment Plant, A Bacterial Model Distinct From Escherichia coli and Enterococci. Environ Sci Technol 45, 5380–5386, http://doi.org/10.1021/es104084c.
Schneider, P., Monsel, G., Veziris, N., Roujeau, J.-C., Bricaire, F. and Caumes, E. (2011). Successful treatment of nodular lymphangitis due to in two immunosuppressed patients. Dermatology Online Journal 17, URL: http://escholarship.org/uc/item/8f55s44k [Accessed September 2013].
Sougakoff, W. (2011). Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis. Clinical Microbiology and Infection 17, 800–805, http://doi.org/10.1111/j.1469-0691.2011.03577.x.
Tochon, M., Bosdure, E., Salles, M., Beloncle, C., Chadelat, K., Dagorne, M., Gaudelus, J., Losi, S., Renoux, M. C., Veziris, N. and Dubus, J. C. (2011). Management of young children in contact with an adult with drug-resistant tuberculosis, France, 2004-2008. Int J Tuberc Lung Dis 15, 326–330.
Truffot-Pernot, C. and Veziris, N. (2011). Les tests bactériologiques de la tuberculose maladie : standards et perspectives. Revue des Maladies Respiratoires 28, 1034–1047, http://doi.org/10.1016/j.rmr.2011.07.002.
van Soolingen, D., Jarlier, V. and Drobniewski, F. (2011). Information for physicians: the laboratory diagnosis of tuberculosis – first steps. In: Mastering the basics of TB control - Development of a handbook on TB diagnostic methods, ECDC, Stockholm, pp. 96–99, URL: doi 10.2900/39099.
Veziris, N., Truffot, C., Mainardi, J.-L. and Jarlier, V. (2011). Activity of carbapenems combined with clavulanate in murine tuberculosis. Antimicrob Agents Chemother, http://doi.org/10.1128/AAC.01824-10.
Veziris, N., Ibrahim, M., Lounis, N., Andries, K. and Jarlier, V. (2011). Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis. PLoS ONE 6, e17556, http://doi.org/10.1371/journal.pone.0017556.